Showing results (161-170 of 195) with videos related to
Sort By:
Pageof 20
Molecules (Basel, Switzerland)|November 26, 2022
Natural Reno-Protective Agents against Cyclosporine A-Induced Nephrotoxicity: An OverviewSabrin R M Ibrahim, Hossam M Abdallah, Ali M El-Halawany, et al.Metabolites|May 26, 2023
Design of Novel Letrozole Analogues Targeting Aromatase for Breast Cancer: Molecular Docking, Molecular Dynamics, and Theoretical Studies on Gold NanoparticlesAlaa Edris, Mohammed Abdelrahman, Wadah Osman, et al.Mini Reviews in Medicinal Chemistry|March 25, 2026
Natural Products as Autophagy-related Protein Kinase Inhibitors: A Future Promising Anticancer from NatureWadah Osman, Mohamed Mirghani, Mona S Mohamed, et al.Journal of Microbiology and Biotechnology|July 25, 2024
Arctigenin from Burdock Root Exhibits Potent Antibacterial and Anti-Virulence Properties against <i>Pseudomonas aeruginosa</i>Abdulrahman E Koshak, Mahmoud A Elfaky, Hossam M Abdallah, et al.Plants (Basel, Switzerland)|October 14, 2022
6-Paradol Alleviates Testosterone-Induced Benign Prostatic Hyperplasia in Rats by Inhibiting AKT/mTOR AxisLenah S Binmahfouz, Haifa Almukadi, Abdulmohsin J Alamoudi, et al.International Immunopharmacology|February 25, 2024
Modulation of the crosstalk between Keap1/Nrf2/HO-1 and NF-κB signaling pathways by Tomatidine protects against inflammation/oxidative stress-driven fulminant hepatic failure in miceWesam H Abdulaal, Ulfat M Omar, Mustafa Zeyadi, et al.Toxicology and Applied Pharmacology|July 17, 2024
Pirfenidone ameliorates ANIT-induced cholestatic liver injury via modulation of FXR, NF-кB/TNF-α, and Wnt/GSK-3β/β-catenin signaling pathwaysWesam H Abdulaal, Ulfat M Omar, Mustafa Zeyadi, et al.Acta Biochimica Polonica|April 17, 2023
Alpha-Mangostin ameliorates acute kidney injury via modifying levels of circulating TNF-α and IL-6 in glycerol-induced rhabdomyolysis animal modelHeba M Eltahir, Hossein M Elbadawy, Ali Alalawi, et al.Journal of Pharmacy & Bioallied Sciences|July 14, 2025
Screening Enamine Fragments Library in the Quest for Novel SOS2 Inhibitors: Pharmacophore Modelling, Molecular Docking, MMGBSA Calculations, and MD SimulationAbdulrahim A Alzain, Mohammed A Almogaddam, Alaa A Makki, et al.Plos One|August 14, 2023
Exploring the potential of approved drugs for triple-negative breast cancer treatment by targeting casein kinase 2: Insights from computational studiesTagyedeen H Shoaib, Walaa Ibraheem, Mohammed Abdelrahman, et al.Pageof 20